If we are to reach the 2030 goals for malaria set by the UN (SDG 3.3) and the WHO (The Global Technical Strategy for Malaria) a broad range of interventions is needed, including medicines which can interrupt the cycle of parasite transmission between humans and mosquitoes.
So far, most medicines for malaria target the pathogenic blood stages and clinically cure the patient. This is a primary focus because it is imperative to deal with the immediate suffering of the individual. However, we also know that to achieve malaria elimination we must attack the parasite on multiple fronts, including curing disease in individuals as well as preventing transmission to the wider population.
This World Mosquito Day, we bring you an image slideshow on the innovative ways in which MMV works in partnership to bring forward medicines which prevent the transmission of malaria.